Transplant House

Analysis

Transplant House is a registered charity in United States, based in Philadelphia, PA. It received its IRS tax-exemption ruling in September 2008, 18 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Transplant House reported income of $2.5m and spending of $2.8m, spending 110% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $3.2m to $2.5m (-20%), an average of -5.4% a year. The sharpest change came in the year to December 2021, when income rose by 31%. Over the whole period it spent 88% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Transplant House sits at the 74th percentile: it is larger than about 74% of them. Against every charity in United States with reported income it ranks in the 88th percentile, and in the 86th percentile within PA. Charities of a similar size with the same main cause include Quality South Inc ($2.5m), Access Tusc ($2.5m) and Norn Group ($2.5m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 79% and program service revenue 14% of the total. Other salaries and wages came to $991k. At year end it held assets of $20.7m against liabilities of $853k, net assets of $19.9m. It reported 30 employees.